{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-059673","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.495091+00:00","generated_at":"2026-05-18T13:34:12.969409+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"InMed Pharma raises $5M in private placement of pre-funded warrants and options","bullets":["Gross proceeds ~$5M from 1,952,363 pre-funded warrants ($0.0001 exercise) and 1,952,363 preferred investment options at $2.436/share.","Amended 199,115 existing options (Oct 2023) from $16.60 to $2.436 per share for $0.125 each.","Proceeds to fund pipeline development, BayMedica commercial sales, and working capital.","H.C. Wainwright acted as placement agent; received 126,904 agent options at $3.2013/share."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-059673","json":"https://secwatch.observer/filing/0001213900-25-059673.json","markdown":"https://secwatch.observer/filing/0001213900-25-059673.md","text":"https://secwatch.observer/filing/0001213900-25-059673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/0001213900-25-059673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/ea0247476-8k_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T13:34:12.969409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}